United States · FDA National Drug Code directory
Irinotecan Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0513_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056
- Product NDC
- 67184-0513
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Irinotecan Hydrochloride
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160503
- Source listing expiry
- 20261231
Source-listed ingredients
- IRINOTECAN HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1 VIAL, SINGLE-USE · 67184-0513-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →